Updated: April 20, 2026
About the program
Program type
Investment stage
Investment focus areas
cell therapy
CBD
biomarkers
protein
celle therapy
proteomics
lifesciences
metabolomics
pharmaceuticals
biotech
transcriptomics
life science
drug
therapeutic
life sciences tools
pharma
medicine
IVD
genomics
life-science
therapeutics
psychedelic
CGT
psychedelics
life sciences
in vitro diagnostics
mRNA
cannabis
metabolites
bio
drugs
lifescience
biopharma
medicines
gene therapy
molecules
Location
Investment offer
Can lead rounds
No
Lead preference
Never
Funding requirements
We invest in early-stage life sciences ventures, including medicine, biotech, and bioengineering.